A novel role of chemerin and CMKLR1 in cardiovascular disease is emerging, both as a consequence of this signaling pathway’s known roles in obesity/metabolic syndrome and inflammation (as outlined above) as well as direct actions on the cardiovascular system. This evidence concerns the gene CMKLR1 and obesity due to melanocortin 4 receptor deficiency.